/ Researchers / investigators / roth-frederick


Dr. Frederick P. Roth

Lunenfeld-Tanenbaum Research Institute
Mount Sinai Hospital
Joseph & Wolf Lebovic Health Complex
991-3 — 600 University
Toronto, Ontario
M5G 1X5

Tel.: 416-586-4800 ext.2215

Fax: 416-586-5993

► Send Email

► Lab Website

► Web of Science Researcher ID

► Publons ID

► Publications


Dr. Frederick P. Roth


Dr. Frederick (Fritz) Roth is an inaugural Canada Excellence Research Chair in Integrative Biology and a Senior Investigator at the Lunenfeld-Tanenbaum Research Institute. Known worldwide for his work in computational biology and genomics, Dr. Roth is jointly appointed at the University of Toronto's Terrence Donnelly Centre for Cellular and Biomolecular Research.

Dr. Roth completed his PhD in biophysics at Harvard University in 1998, after studying both physics and molecular and cell biology at the University of California, Berkeley. His most recent position before joining the Lunenfeld was at Harvard Medical School, where he was an Associate Professor in the Department of Biological Chemistry and Molecular Pharmacology.

His research focuses on developing technologies to more efficiently relate genes to the functioning of living systems and human diseases. These new technologies will accelerate researchers' studies of genes, their functions and how these functions interact to form living systems.

Building on their previous work in experimental and computational genomics, Dr. Roth's team will collaborate with other Lunenfeld researchers in the Systems Biology group to develop new technologies for revealing gene functions, the pathways they encode and how these genes and pathways are related to human diseases. Dr. Roth's group is harnessing “next generation†DNA sequencing technologies to systematically measure the effects of multiple genetic changes, and to map protein interactions.

Large-scale experimentation on biological model systems by Dr. Roth and others in the Systems Biology group is uncovering fundamental aspects of protein, cell and organismal function to better understand human health and disease.

Early work by Dr. Roth demonstrated that DNA sequence elements controlling genes can be automatically discovered using large-scale measurements of the levels at which genes are activated.

His group has extensively studied the networks of interactions between proteins in yeast, worms, plants and humans. More recently, Dr. Roth's team has computationally prioritized candidate disease genes so that researchers can focus efforts on the genes most likely to impact human health.

At a Glance

Dr. Roth is a Canada Excellence Research Chair in Integrative Biology, a Lunenfeld Senior Investigator and is cross-appointed at the University of Toronto's Donnelly Centre for Cellular and Biomolecular Research.

His team is at the forefront of developing new technologies to accelerate researchers' studies of genes, their functions and how these functions interact to form living systems.

Dr. Roth is a leading international expert in genomics and is using large-scale, sophisticated DNA sequencing techniques to uncover and understand interactions between genes and the proteins they encode.

Studies in his group range from basic research in model organisms (e.g., studying DNA repair systems in yeast) to humans (e.g., discovering host factors important for human viruses).

By developing, integrating and applying experimental and computational technologies, Dr. Roth's team is working to understand biomolecular pathways and their relationship to human health.

Major Research Activities

With an extensive track record of innovation in experimental and computational genomics, Dr. Roth's team is developing new technologies to accelerate discoveries of gene functions, the pathways they encode and the relationships to human illnesses. A flagship project is Barcode Fusion Genetics (BFG), a sequencing-based experimental technology to measure the effects of multiple genetic changes in yeast and human cells. The BFG method is also being adapted to identify networks of protein interactions and how cancer-causing mutations in key regulatory proteins can alter these networks. His team is also developing new methods to lower the cost of DNA sequencing, and they are using computational approaches to determine the order in which genes act within genetic pathways. Through these and other projects, Dr. Roth endeavours to identify and prioritize candidate genes toward improved understanding of the causes and cures of diseases including cancer.




  About Us
   Senior Administration
   Research Committee
   Canada Research Continuity Emergency Fund
    Funding Opportunities
     CRCEF - Stage 3
   Canada Research Chairs
   Technology Transfer
   Career Opportunities
    Dr. Irene L. Andrulis
    Dr. Rod Bremner
    Dr. Laurent Briollais
    Dr. Theodore J. Brown
    Dr. Shelley B. Bull
    Dr. Kieran Campbell
    Dr. Isabella Caniggia
    Dr. Robert F. Casper
    Dr. Graham L. Collingridge
    Dr. Sabine P. Cordes
    Dr. Joseph Culotti
    Dr. James Dennis
    Dr. Daniel J. Drucker
    Dr. Daniel Durocher
    Dr. Steven Gallinger
    Dr. Anne-Claude Gingras
    Dr. Pamela Goodwin
    Dr. Marc D. Grynpas
    Dr. Rayjean J. Hung
    Dr. Hartland W. Jackson
    Dr. Andrea Jurisicova
    Dr. Julia A. Knight
    Dr. Alexander G. Logan
    Dr. Stephen J. Lye
    Dr. Andras Nagy
    Dr. Michelle Nelson
    Dr. Kenichi Okamoto
    Dr. Laurence Pelletier
    Dr. Miguel Ramalho-Santos
    Dr. Frederick P. Roth
    Dr. Daniel Schramek
    Dr. Frank Sicheri
    Dr. Mark S. Silverberg
    Dr. Katherine Siminovitch
    Dr. Carolyn Steele Gray
    Dr. Ross Upshur
    Dr. Jim R. Woodgett
    Dr. Jeffrey Wrana
    Dr. Mei Zhen
    Dr. Bernard Zinman
   Clinician Scientists
    Dr. May Alarab
    Dr. Dominic Amato
    Dr. Amir Azarpazhooh
    Dr. Mrinalini Balki
    Dr. Chaim Bell
    Dr. Christine Brezden-Masley
    Dr. June C. Carroll
    Dr. Crystal Chan
    Dr. Kenneth Croitoru
    Dr. Ariel Dalfen
    Dr. Allan Detsky
    Dr. Brendan C. Dickson
    Dr. Rohan D. D’Souza
    Dr. Denice S. Feig
    Dr. Emer Finan
    Dr. John S. Floras
    Dr. Michael Fralick
    Dr. Shiphra R. Ginsburg
    Dr. Rebecca A. Gladdy
    Dr. Michael Goldberg
    Dr. Ellen Greenblatt
    Dr. Masoom A. Haider
    Dr. Jonathan J. Hunter
    Dr. Amna F. Husain
    Dr. Amish Jain
    Dr. Keith A. Jarvi
    Dr. Lianne P. Jeffs
    Dr. Jennie Johnstone
    Dr. Rita Kandel
    Dr. Edmond Kelly
    Dr. Erin D. Kennedy
    Dr. Edward C. Keystone
    Dr. James Khan
    Dr. John Kingdom
    Dr. Richard Kirsch
    Dr. Elena Kolomietz
    Dr. Caroline K. Kramer
    Dr. Stephen Lapinsky
    Dr. Shoo K. Lee
    Dr. Molyn Leszcz
    Dr. Susanna Mak
    Dr. Ann K. Malinowski
    Dr. Robert G. Maunder
    Dr. Taymaa May
    Dr. Allison McGeer
    Dr. Warren McIsaac
    Dr. Sangeeta Mehta
    Dr. Shikha Mittoo
    Dr. Ally Murji
    Dr. Kellie E. Murphy
    Dr. Geoffrey C. Nguyen
    Dr. Karel O'Brien
    Dr. Christian Pagnoux
    Dr. Claire Pain
    Dr. John Parker
    Dr. Bruce A. Perkins
    Dr. Allan Peterkin
    Dr. Aaron F. Pollett
    Dr. Paula Ravitz
    Dr. Albiruni A. Razak
    Dr. Ravi Retnakaran
    Dr. Robert H. Riddell
    Dr. Greg Ryan
    Dr. Joel Sadavoy
    Dr. Francisco J. Sanchez-Guerrero
    Dr. Amanda Selk
    Dr. Prakeshkumar Shah
    Dr. Vibhuti Shah
    Dr. Naveed Tahir Siddiqui
    Dr. Candice K. Silversides
    Dr. Daisy R. Singla
    Dr. Kim Tsoi
    Dr. Hillary A. Steinhart
    Dr. Carol Swallow
    Dr. Howard C. Tenenbaum
    Dr. Sharon L. Unger
    Dr. Chen Wang
    Dr. Alanna Weisman
    Dr. Virginia A. Wesson
    Dr. Lesley Wiesenfeld
    Dr. Rory Windrim
    Dr. Jay Wunder
    Dr. Alexandre Zlotta
   Staff Scientists
    Dr. Karen Colwill
    Dr. John Georgiou
    Dr. Colin Mckerlie
    Dr. Jinyi Zhang
   Associate Members / Scientists
    Dr. Gary D. Bader
    Dr. Bharati Bapat
    Dr. Marcus Bernardini
    Dr. Lisa D. Burry
    Dr. George S. Charames
    Dr. Mary Chiu
    Dr. Eleftherios P. Diamandis
    Dr. Sarah Ferguson
    Dr. Michael Glogauer
    Dr. Jack M. Goodman
    Dr. Tae Hart
    Dr. Johannes Keunen
    Dr. Jordan Lerner-Ellis
    Dr. Zhong-Cheng Luo
    Dr. Stephen G. Matthews
    Dr. John R. McLaughlin
    Dr. Helen McNeill
    Dr. Massieh Moayedi
    Dr. Abdul Noor
    Dr. Ian M. Rogers
    Dr. Mike Tyers
   Physician Directory
   Our Research
  Trainee Centre
   Summer Research Program
    Innovations in prostate cancer research during moustache season and beyond
    New genetic discoveries offer hope to IBD patients
    Diabetes: disease of the 21st century will affect approximately 500 million by 2030
    What does a worm’s nervous system tell us about disorders like Huntington’s Disease?
    The Year in Review: 2012 Highlights from the Samuel Lunenfeld Research Institute
    Millennials Help Scientists Transform Breast Cancer Research
    How Research Impacts Your Health
    2013 International Symposium: Frontiers in Diabetes Research
    $35 Million Gift from Larry and Judy Tanenbaum Launches Fundraising Drive for Endowment to Support Medical Research
    Director warns why we shouldn't neglect basic science in favour of applied science
    The anatomy of a major discovery
    Unravelling the mysteries of complex brain disorders
    LTRI Q&A: How do we predict breast cancer risk more effectively?
    Michal Zimmermann and his efforts to improve cancer drug efficacy
    Dheva Setiaputra
    Salomé Adam
   Discovery Corner
    Not your typical March Break: the life of an intern at the LTRI
   Slides relating to the recommendations of CANADA'S FUNDAMENTAL SCIENCE REVIEW